Interaction of insulin-like growth factor-I and insulin resistance - related genetic variants with lifestyle factors on postmenopausal breast cancer risk

作者: Su Yon Jung , Gloria Ho , Thomas Rohan , Howard Strickler , Jennifer Bea

DOI: 10.1007/S10549-017-4272-Y

关键词:

摘要: Genetic variants and traits in metabolic signaling pathways may interact with obesity, physical activity, exogenous estrogen (E), influencing postmenopausal breast cancer risk, but these inter-related are incompletely understood. We used 75 single-nucleotide polymorphisms (SNPs) genes related to insulin-like growth factor-I (IGF-I)/insulin resistance (IR) pathways, data from 1003 women Women’s Health Initiative Observation ancillary studies. Stratifying via obesity lifestyle modifiers, we assessed the role of IGF-I/IR (fasting IGF-I, IGF-binding protein 3, insulin, glucose, homeostatic model assessment-insulin resistance) risk as a mediator or factor. Seven SNPs IGF-I INS were associated risk. These associations differed between non-obese/active obese/inactive E non-users users. The mediation effects on relationship strata, only roughly 35% due was mediated by traits. Similarly, carriers 20 PIK3R1, AKT1/2, MAPK1 (signaling pathways–genetic variants) had different proportion SNP–cancer explained varied 45–50% strata. Our findings suggest that genetic factors, altering partially through other than Unraveling gene–phenotype–lifestyle interactions will provide potential targets clinical trials for prevention intervention strategies reduce

参考文章(57)
J. G. Anderson, Surgical Training, Error JAMA. ,vol. 291, pp. 1775- 1776 ,(2004) , 10.1001/JAMA.291.14.1775
Niyati Parekh, Guia Guffanti, Yong Lin, Heather M. Ochs-Balcom, Nour Makarem, Richard Hayes, Insulin receptor variants and obesity-related cancers in the Framingham Heart Study Cancer Causes & Control. ,vol. 26, pp. 1189- 1195 ,(2015) , 10.1007/S10552-015-0613-5
Adams-Campbell Ll, Agurs-Collins T, Cullen Kj, Kim Ks, Insulin-like growth factor-1 and breast cancer risk in postmenopausal African-American women. Cancer Detection and Prevention. ,vol. 24, pp. 199- 206 ,(2000)
Writing Group for the Women's Health Initiative Investigators, Writing Group for the Women's Health Initiative Investigators, None, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial JAMA. ,vol. 288, pp. 321- 333 ,(2002) , 10.1001/JAMA.288.3.321
Jennifer J. Wheler, Johnique T. Atkins, Filip Janku, Stacy L. Moulder, Roman Yelensky, Philip J. Stephens, Razelle Kurzrock, Multiple gene aberrations and breast cancer: lessons from super-responders BMC Cancer. ,vol. 15, pp. 442- 442 ,(2015) , 10.1186/S12885-015-1439-Y
Rulla M Tamimi, David G Cox, Peter Kraft, Michael N Pollak, Christopher A Haiman, Iona Cheng, Matthew L Freedman, Susan E Hankinson, David J Hunter, Graham A Colditz, Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study Breast Cancer Research. ,vol. 9, pp. 1- 13 ,(2007) , 10.1186/BCR1655
K DeLellis, S Ingles, L Kolonel, R McKean-Cowdin, B Henderson, F Stanczyk, N M Probst-Hensch, IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort British Journal of Cancer. ,vol. 88, pp. 277- 282 ,(2003) , 10.1038/SJ.BJC.6600728
David P. MacKinnon, Ghulam Warsi, James H. Dwyer, A Simulation Study of Mediated Effect Measures Multivariate Behavioral Research. ,vol. 30, pp. 41- 62 ,(1995) , 10.1207/S15327906MBR3001_3
Qiong Wang, Li Liu, Hui Li, Lauren E McCullough, Ya-na Qi, Jia-yuan Li, Jing Zhang, Erline Miller, Chun-xia Yang, Jennifer S Smith, None, Genetic and Dietary Determinants of Insulin-Like Growth Factor (IGF)-1 and IGF Binding Protein (BP)-3 Levels among Chinese Women PLoS ONE. ,vol. 9, pp. e108934- ,(2014) , 10.1371/JOURNAL.PONE.0108934